Natural Variants of the Immunodominant HLA A11-Restricted CTL Epitope of the EBV Nuclear Antigen-4 Are Nonimmunogenic Due to Intracellular Dissociation from MHC Class I:Peptide Complexes

Journal of Immunology

Volumn 159, Issue 11, 1997, Pages 5383-5390

  Levitsky, Victor ^a   Zhang, Qian Jin ^a,c   Levitskaya, Jelena ^a   Kurilla, Michael G ^b   Masucci, Maria G ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; EPSTEIN BARR VIRUS ANTIGEN; HLA A ANTIGEN; HLA A11; HLA ANTIGEN CLASS 1; HLA-A11; PEPTIDE;

ARTICLE; CELL LINE; CYTOTOXIC T LYMPHOCYTE; GENETIC VARIABILITY; HUMAN; IMMUNOLOGY;

CELL LINE, TRANSFORMED; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-A ANTIGENS; HUMANS; IMMUNODOMINANT EPITOPES; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC; VARIATION (GENETICS);

EID: 0031307529     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Kägi, D., B. Ledermann, K. Bürki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31.
2. Guidotti, L. G., and F. V. Chisari. 1996. To kill or to cure: options in host defence against viral infection. Curr. Opin. Immunol. 8:478.
3. Koup, R. A. 1994. Virus escape from CTL recognition. J. Exp. Med. 180:779.
4. Pewe, L., G. F. Wu, E. M. Barnett, R. F. Castro, and S. Perlman. 1996. Cytotoxic T-cell-resistant variants are selected in a virus-induced demyelinating disease. Immunity 5:253.
5. Townsend, A., J. Rothbard, F. Gotch, B. Bahadur, D. Wraith, and A. McMichael. 1986. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44:959.
6. Ehrlich, R. 1995. Selective mechanisms utilized by persistent and oncogenic viruses to interfere with antigen processing and presentation. Immunol. Res. 14: 77.
7. Ploegh, H. L. 1995. Trafficking and assembly of MHC molecules: how viruses elude the immune system. Cold Spring Harbor Symp. Quant. Biol. 60:263.
8. Niedermann, G., S. Butz, H. G. Ihlenfeldt, R. Grimm, M. Lucchiari, H. Hoschützky, G. Jung, B. Maier, and K. Eichmann. 1995. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Immunity 2:289.
9. Shepherd, J. C., T. N. M. Schumacher, P. G. Ashton-Rickardt, S. Imaeda, H. L. Ploegh, C. A. Janeway, and S. Tonegawa. 1993. TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective. Cell 74:577.
10. Engelhard, V. H. 1994. Structure of peptides associated with class I and class II MHC molecules. Annu. Rev. Immunol. 12:181.
11. de Magistris, M. T., J. Alexander, M. Coggeshall, A. Altmon, F. C. A. Gaeta, H. M. Grey, and A. Sette. 1992. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell 68:625.
12. Couillin, I., F. Connan, B. Culmann-Penciolelli, E. Gomard, J. G. Guillet, and J. Choppin. 1995. HLA-dependent variations in human immunodeficiency virus Nef protein alter peptide/HLA binding. Eur. J. Immunol. 25:728.
13. Ossendorp, F., M. Eggers, A. Heisig, T. Ruppert, M. Groettrup, A. Sijts, E. Mengede, P.-M. Kloetzel, J. Neefjes, U. Koszinowski, and C. Melief. 1996. A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. Immunity 5:115.
14. Klenerman, P., S. Rowland-Jones, S. McAdam, J. Edwards, S. Daenke, D. Lallo, B. Köppe, W. Rosenberg, D. Boyd, A. Edwards, P. Giangrande, R. E. Phillips, and A. J. McMichael. 1994. Cytotoxic T-cell activity antagonized by naturally occurring HIV Gag variants. Nature 369:403.
15. Lewicki, H., A. Tishon, P. Borrow, C. F. Evans, J. E. Gairin, K. M. Hahn, D. A. Jewell, I. A. Wilson, and M. B. Oldstone. 1995. CTL escape viral variants. I. Generation and molecular characterization. Virol. 210:29.
16. Bertoletti, A., A. Costanzo, F. V. Chisari, M. Levrero, M. Artini, A. Sette, A. Penna, T. Giuberti, F. Fiaccadori, and C. Ferrari. 1994. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J. Exp. Med. 180:933.
17. Pircher, H., D. Moskophidis, U. Rohrer, K. Bürki, H. Hengartner, and R. M. Zinkernagel. 1990. Virus escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature 346:629.
18. Borrow, P., H. Lewicki, X. Wei, M. S. Horwitz, N. Peffer, H. Meyers, J. A. Nelson, J. E. Gairin, B. H. Hahn, M. B. A. Oldstone, and G. M. Shaw. 1997. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat. Med. 3:205.
19. Couillin, I., P. B. Culmann, E. Gomard, J. Choppin, J. P. Levy, J. G. Guillet, and S. Saragosti. 1994. Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein. J. Exp. Med. 180:1129.
20. + population. Science 260:98.
21. Goulder, P. J., R. E. Phillips, R. A. Colbert, S. McAdam, G. Ogg, M. A. Nowak, P. Giangrande, G. Luzzi, B. Morgan, A. Edwards, A. J. McMichael, and S. Rowland-Jones. 1997. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat. Med. 3:212.
22. de Campos-Lima, P.-O., V. Levitsky, J. Brooks, S. P. Lee, L.-F. Hu, A. B. Rickinson, and M. G. Masucci. 1994. T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues. J. Exp. Med. 179:1297.
23. Gavioli, R., M. G. Kurilla, P. De Campos-Lima, L. E. Wallace, D. Dolcetti, R. J. Murray, A. B. Rickinson, and M. G. Masucci. 1993. Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4. J. Virol. 67:1572.
24. Miller, G., and M. Lipman. 1973. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc. Natl. Acad. Sci. USA 70:190.
25. Zhang, Q.-J., R. Gavioli, G. Klein, and M. G. Masucci. 1993. An HLA A11-specific motif in nonamer peptides derived from viral and cellular proteins. Proc. Natl. Acad. Sci. USA 90:2217.
26. Hirs, C., and S. Timasheff. 1977. Methods of Peptide Synthesis. Academic Press, New York.
27. Dumas, B. 1975. Standards for total serum protein assays: a collaborative study. Clin. Chem. 21:1159.
28. Torsteinsdottir, S., M. G. Masucci, C. Brautbar, G. Lenoir, G. Klein, and E. Klein. 1986. Differential recognition of tumor derived and in vitro Epstein-Barr virus (EBV) transformed B cell lines by FCS specific T4 positive CTL clones. Cell. Immunol. 98:453.
29. Rabin, H., R. F. Hopkins, F. W. Ruscetti, R. H. Neubawer, R. L. Brown, and T. G. Kawakami. 1981. Spontaneous release of a factor with properties of T-cell growth factor from a continuous line of primate tumor T cells. J. Immunol. 127: 1852.
30. Falk, K., O. Rötzschke, S. Stevanovic, G. Jung, and H.-G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290.
31. Momburg, F., J. Roelse, J. C. Howard, G. W. Butcher, G. J. Hammerling, and J. J. Neefjes. 1994. Selectivity of MHC-encoded peptide transporters from human, mouse and rat. Nature 367:648.
32. Neefjes, J., B. Breur-Vrisendorp, G. van Seventer, P. Ivany, and H. Ploegh. 1986. An improved biochemical method for analysis of HLA class I antigens. Hum. Immunol. 16:169.
33. Barnstable, C., W. Bodmer, G. Brown, G. Galfre, C. Milstein, A. Williams, and A. Ziegler. 1978. Production of monoclonal antibodies to group A erythrocytes, HLA and other cell surface antigens: new tools for genetic analysis. Cell 14:9.
34. Coligan, J. E. 1996. Current Protocols in Immunology, Vol. 2. R. Coico, ed. John Wiley & Sons, Inc., pp. 8.11.1-8.11.4.
35. Murray, R. J., M. G. Kurilla, H. M. Griffin, J. M. Brooks, M. Mackett, J. R. Arrand, M. Rowe, S. R. Burrows, D. J. Moss, E. Kieff, and A. B. Rickinson. 1990. Human cytotoxic T cell responses against Epstein-Barr virus nuclear antigens demonstrated using recombinant vaccinia viruses. Proc. Natl. Acad. Sci. USA 87:2906.
36. Levitsky, V., Q. J. Zhang, J. Levitskaya, and M. G. Masucci. 1996. The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4. J. Exp. Med. 183: 915.
37. Goulder, P. J. R., A. K. Sewell, D. G. Lalloo, D. A. Price, J. A. Whelan, J. Evans, G. P. Taylor, G. Luzzi, P. Giangrande, R. E. Phillips, and A. J. McMichael. 1997. Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)-identical siblings with HLA-A*0201 are influenced by epitope mutation. J. Exp. Med. 185: 1423.
38. Tsomides, T. J., A. Aldovini, R. P. Johnson, B. D. Walker, R. A. Young, and H. N. Eisen. 1994. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. J. Exp. Med. 180:1283.
39. Palmer, E. G. 1994. Direct sequence identification and kinetic analysis of an MHC class I restricted Listeria monocytogenes CTL epitope. J. Immunol. 152: 686.
40. Falk, K., O. Rötzschke, K. Deres, G. Metzger, G. Jung, and H. G. Rammensee. 1991. Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast. J. Exp. Med. 174:425.
41. Tussey, L. G., S. Rowland-Jones, T. S. Zheng, M. J. Androlewicz, P. Cresswell, J. A. Frelinger, and A. J. McMichael. 1995. Different MHC class I alleles compete for presentation of overlapping viral epitopes. Immunity 3:65.
42. Nelson, C. A., S. J. Petzold, and E. R. Unanue. 1994. Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell. Nature 250: 250.
43. David-Watine, B., A. Israel, and P. Kourilsky. 1990. The regulation and expression of MHC class I genes. Immunol. Today 11:286.
44. Sykulev, Y., J. Michael, I. Vturina, T. J. Tsomides, and H. N. Eisen. 1996. Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity 4:565.
45. Ljunggren, H. G., N. S. Stam, C. Ohlén, J. J. Neefjes, P. Höglund, M. T. Heemels, J. Bastin, T. N. M. Schumacher, A. Townsend, K. Kärre, and H. L. Ploegh. 1990. Empty MHC class I molecules come out in the cold. Nature 346:476.
46. Baas, E. J., H.-M. van Santen, M. J. Kleijmeer, H. J. Geuze, P. J. Peters, and H. L. Ploegh. 1992. Peptide-induced stabilization and intracellular localization of empty HLA class I complexes. J. Exp. Med. 176:147.
47. Sijts, A. J. A. M., and E. G. Pamer. 1997. Enchanced intracellular dissociation of major histocompatibility complex class I-associated peptides: a mechanism for optimizing the spectrum of cell surface-presented cytotoxic T lymphocyte epitopes. J. Exp. Med. 185:1403.
48. Andersen, P. S., A. Stryhn, B. E. Hansen, L. Fugger, J. Engberg, and S. Buus. 1996. A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells. Proc. Natl. Acad. Sci. USA 93:1820.